Nutraceuticals silybin B, resveratrol, and epigallocatechin-3 gallate-bind to cardiac muscle troponin to restore the loss of lusitropy caused by cardiomyopathy mutations in vitro, in vivo, and in silico
Introduction: Adrenergic activation of protein kinase A (PKA) in cardiac muscle targets the sarcolemma, sarcoplasmic reticulum, and contractile apparatus to increase contractile force and heart rate. In the thin filaments of the contractile apparatus, cardiac troponin I (cTnI) Ser22 and Ser23 in the...
Main Authors: | Yang, Z, Sheehan, AM, Messer, AE, Tsui, S, Sparrow, A, Redwood, C, Kren, V, Gould, IR, Marston, SB |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Frontiers Media
2024
|
Similar Items
-
Targeted gastrointestinal delivery of nutraceuticals with polysaccharide-based coatings
by: Sampathkumar, Kaarunya, et al.
Published: (2022) -
Muslim consumers’ behaviour towards halal nutraceutical products in Malaysia
by: Siti Nurunnajwa, S., et al.
Published: (2024) -
From agro-waste to bioactive wealth: Analyzing nutraceutical extraction and applications
by: Alazaiza Motasem, Y. D., et al.
Published: (2025) -
Genome-wide association analysis provides insights into the molecular etiology of dilated cardiomyopathy
by: Zheng, SL, et al.
Published: (2024) -
Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy
by: Raj Murthi, S, et al.
Published: (2025)